Correlation Between Enliven Therapeutics and AbbVie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and AbbVie Inc, you can compare the effects of market volatilities on Enliven Therapeutics and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and AbbVie.

Diversification Opportunities for Enliven Therapeutics and AbbVie

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Enliven and AbbVie is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and AbbVie go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and AbbVie

Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the AbbVie. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.01 times less risky than AbbVie. The stock trades about -0.19 of its potential returns per unit of risk. The AbbVie Inc is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest  20,387  in AbbVie Inc on September 1, 2024 and sell it today you would lose (2,094) from holding AbbVie Inc or give up 10.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Enliven Therapeutics  vs.  AbbVie Inc

 Performance 
       Timeline  
Enliven Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
AbbVie Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental drivers, AbbVie is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Enliven Therapeutics and AbbVie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enliven Therapeutics and AbbVie

The main advantage of trading using opposite Enliven Therapeutics and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.
The idea behind Enliven Therapeutics and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios